UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema

Journal of allergy and clinical immunology, 2010-10, Vol.126 (4), p.821-827.e14

2010

Volltextzugriff (PDF)

Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits

Journal of biotechnology, 2012-12, Vol.162 (2-3), p.319-326

2012

Volltextzugriff (PDF)

Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients

The American journal of medicine, 2012-09, Vol.125 (9), p.937.e17-937.e24

2012

Volltextzugriff (PDF)

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

Journal of Allergy and Clinical Immunology, 2004-09, Vol.114 (3), p.S51-S131

2004

Volltextzugriff (PDF)

Large scale production of recombinant human lactoferrin in the milk of transgenic cows

Nature biotechnology, 2002-05, Vol.20 (5), p.484-487

2002

Volltextzugriff (PDF)

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks

Transfusion (Philadelphia, Pa.), 2007-06, Vol.47 (6), p.1028-1032

2007

Volltextzugriff (PDF)

N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits

Glycobiology (Oxford), 2004-01, Vol.14 (1), p.51-64

2004

Volltextzugriff (PDF)

protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin

Transgenic research, 2005-08, Vol.14 (4), p.397-405

2005

Volltextzugriff (PDF)

The role of N‐linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis

European journal of biochemistry, 2004-02, Vol.271 (4), p.678-684

2004

Volltextzugriff (PDF)

Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Frontiers in psychiatry, 2021-04, Vol.12, p.639393

2021

Volltextzugriff (PDF)

The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus

Biochimica et biophysica acta, 2001-12, Vol.1568 (3), p.197-204

2001

Volltextzugriff (PDF)

Structure and biological actions of lactoferrin

Journal of mammary gland biology and neoplasia, 1996-07, Vol.1 (3), p.285-295

1996

Volltextzugriff (PDF)

Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin

Analytical biochemistry, 2002-10, Vol.309 (1), p.60-66

2002

Volltextzugriff (PDF)

Characterization of monoclonal antibodies against human lactoferrin

Journal of immunological methods, 2002-09, Vol.267 (2), p.139-150

2002

Volltextzugriff (PDF)

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

Journal of Allergy and Clinical Immunology, 2005-10, Vol.116 (4), p.876-883

2005

Volltextzugriff (PDF)

Charge modification of plasma and milk proteins results in antiviral active compounds

Journal of peptide science, 1999-12, Vol.5 (12), p.563-576

1999

Volltextzugriff (PDF)

Characterization of Recombinant Human Lactoferrin Secreted in Milk of Transgenic Mice

The Journal of biological chemistry, 1997-03, Vol.272 (13), p.8802-8807

1997

Volltextzugriff (PDF)

Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1

The Journal of experimental medicine, 1998-09, Vol.188 (6), p.1091-1103

1998

Volltextzugriff (PDF)

Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation

Thrombosis and haemostasis, 1998-10, Vol.80 (4), p.686

1998

Volltextzugriff (PDF)

Expression of human lactoferrin in milk of transgenic mice

Transgenic research, 1994-03, Vol.3 (2), p.99-108

1994

Volltextzugriff (PDF)

Granulocyte Colony-Stimulating Factor Administration to Healthy Volunteers: Analysis of the Immediate Activating Effects on Circulating Neutrophils

Blood, 1994-12, Vol.84 (11), p.3685-3694

1994

Volltextzugriff (PDF)

Increased Plasma Levels of Interleukin-6 in Sepsis

Blood, 1989-10, Vol.74 (5), p.1704-1710

1989

Volltextzugriff (PDF)

Inactivation of Factor XIa in Human Plasma Assessed by Measuring Factor XIa-Protease Inhibitor Complexes: Major Role for C1-Inhibitor

Blood, 1995-03, Vol.85 (6), p.1517-1526

1995

Volltextzugriff (PDF)

Soluble Fcγ receptor III in human plasma originates from release by neutrophils

The Journal of clinical investigation, 1990-08, Vol.86 (2), p.416-423

1990

Volltextzugriff (PDF)

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

Molecular immunology, 2008-10, Vol.45 (16), p.4118-4119

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(66)

Sprache

Englisch
(65)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Humans
(39)
Life Sciences & Biomedicine
(38)
Biological And Medical Sciences
(21)
Animals
(17)
Female
(15)
Biochemistry & Molecular Biology
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Male
(12)
Medical Sciences
(12)
Lactoferrin - Metabolism
(10)
Mice
(10)
Lactoferrin - Chemistry
(9)
Lactoferrin - Genetics
(9)
Recombinant Proteins - Chemistry
(9)
Adult
(8)
Amino Acid Sequence
(8)
Cattle
(8)
Glycosylation
(7)
Immunology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema

Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits

Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

Large scale production of recombinant human lactoferrin in the milk of transgenic cows

Recombinant human C1-inhibitor in the treatment of acute angioedema attacks

N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits

protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin

The role of N‐linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis

Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus

Structure and biological actions of lactoferrin

Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin

Characterization of monoclonal antibodies against human lactoferrin

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

Charge modification of plasma and milk proteins results in antiviral active compounds

Characterization of Recombinant Human Lactoferrin Secreted in Milk of Transgenic Mice

Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1

Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation

Expression of human lactoferrin in milk of transgenic mice

Granulocyte Colony-Stimulating Factor Administration to Healthy Volunteers: Analysis of the Immediate Activating Effects on Circulating Neutrophils

Increased Plasma Levels of Interleukin-6 in Sepsis

Inactivation of Factor XIa in Human Plasma Assessed by Measuring Factor XIa-Protease Inhibitor Complexes: Major Role for C1-Inhibitor

Soluble Fcγ receptor III in human plasma originates from release by neutrophils

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

Suchergebnisse filtern